Johnson & Johnson | featured news

Heir to Johnson & Johnson fortune dies at 76

The family of Barbara Piasecka Johnson, a Polish farmer's daughter who worked as a maid for an American heir to the Johnson & Johnson fortune before marrying him and eventually inheriting much of his wealth, says she has died. She was 76....


Berkshire Hathaway Buys Wells Fargo, DaVita HealthCare, Mondelez, Sells Kraft Foods, Johnson & Johnson

This the latest portfolio update for Berkshire Hathaway. Warren Buffett continued to add to his favorite companies such as Wells Fargo and IBM, while his new managers Ted Weschler and Todd Combs bought into three new positions and added to existing positions.


J&J will remove dangerous chemicals from products by 2015

Baby products, including No More Tears shampoo, will be safer by end of 2013. Adult products by the end of 2015.


Hormone Drug Slows Prostate Cancer Growth

Johnson & Johnson's drug Zytiga slowed the growth of prostate cancer in a clinical trial of men who hadn't undergone chemotherapy.


DealBook: Avon Appoints New Chief Executive


Sherilyn S. McCoy, a vice chairman of Johnson & Johnson, is the new chief executive of Avon Products.


J&J CEO Could Get $143.5 Million Retirement Package

Johnson & Johnson CEO William Weldon stands to collect pension benefits and deferred compensation valued at $143.5 million after his retirement, according to new details released by the health-care conglomerate.


Johnson & Johnson Ordered to Pay $327 Million

A South Carolina judge ordered Johnson & Johnson to pay the state $327 million in civil penalties after a jury concluded earlier this year the company misled doctors about the safety and effectiveness of antipsychotic Risperdal.


J&J to buy Synthes for $21.5 billion: report

J&J to buy Synthes for $21.5 billion: report

Johnson & Johnson is to buy Swiss medical devices maker Synthes Inc in a deal worth $21.3 billion, its largest ever buy, boosting its orthopedics franchise and reshaping the medical technology industry.


Johnson & Johnson to Reorganize Troubled Tylenol Unit

Johnson & Johnson is revamping the troubled unit that makes Tylenol and giving it new leadership in an effort to fix quality problems that have prompted multiple recalls, according to people familiar with the matter.


9 million bottles of Tylenol recalled

Johnson & Johnson said on Wednesday that it was recalling 9 million more bottles of its Tylenol painkiller because they did not adequately warn customers about the presence of trace amounts of alcohol used in the product flavorings.


Subscribe to this RSS topic: Syndicate content